Healthcare & Life Sciences
Obsidian Therapeutics
United Statesobsidiantherapeutics.com
activeseries-c-plus
series-c-plus
Stage
2017
Founded
2
Investors
About
Obsidian Therapeutics is a biotechnology company focused on developing novel cell therapies using synthetic biology to improve immune system regulation.
Explore Obsidian Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.